
Acenocoumarol tablet
Form: Tablet
Strength: 1 mg, 2 mg, 4 mg
Reference Brands: Sintrom(EU)
Category: Blood Disorder
Acenocoumarol is a registered oral anticoagulant primarily used in the EU for managing thromboembolic disorders. In the EU, it is approved by the EMA under centralized or national authorization processes, with a comprehensive dossier demonstrating safety, efficacy, and quality. In the US, acenocoumarol is not widely marketed; Warfarin is the preferred anticoagulant. For successful registration, dossier preparation, and regulatory compliance, visit PharmaTradz. Ensuring adherence to regional regulations and pharmacovigilance standards is essential for market approval and safe use of acenocoumarol in different territories.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Anti-Inhibitor Coagulant Complex (AICC) Lyophilized Powder
Strength: 500 units, 1000 units, and 2500 units
Form: Lyophilized Powder (Reconstituted for IV infusion)
Reference Brands: FEIBA(US)
View Details Get EnquiryProthrombin Complex Concentrate (PCC) injection
Strength: 250 IU to 300 IU
Form: Injection
Reference Brands: Kcentra (4-factor PCC), Bebulin VH (3-factor PCC)(US)
View Details Get EnquiryMesna Injection
Strength: 100 mg/mL
Form: Injection
Reference Brands: Mesnex(US)
View Details Get EnquiryLeucovorin tablets/Capsule
Strength: 15 mg, 50 mg
Form: Tablet/Capsules
Reference Brands: Folvite(US & EU)
View Details Get Enquiry